226 related articles for article (PubMed ID: 7809121)
1. Sodium channel mutations in paramyotonia congenita exhibit similar biophysical phenotypes in vitro.
Yang N; Ji S; Zhou M; Ptácek LJ; Barchi RL; Horn R; George AL
Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12785-9. PubMed ID: 7809121
[TBL] [Abstract][Full Text] [Related]
2. Paramyotonia congenita mutations reveal different roles for segments S3 and S4 of domain D4 in hSkM1 sodium channel gating.
Ji S; George AL; Horn R; Barchi RL
J Gen Physiol; 1996 Feb; 107(2):183-94. PubMed ID: 8833340
[TBL] [Abstract][Full Text] [Related]
3. Two human paramyotonia congenita mutations have opposite effects on lidocaine block of Na+ channels expressed in a mammalian cell line.
Fan Z; George AL; Kyle JW; Makielski JC
J Physiol; 1996 Oct; 496 ( Pt 1)(Pt 1):275-86. PubMed ID: 8910215
[TBL] [Abstract][Full Text] [Related]
4. Sodium channel mutations in paramyotonia congenita and hyperkalemic periodic paralysis.
Ptacek LJ; Gouw L; Kwieciński H; McManis P; Mendell JR; Barohn RJ; George AL; Barchi RL; Robertson M; Leppert MF
Ann Neurol; 1993 Mar; 33(3):300-7. PubMed ID: 8388676
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization and cold sensitivity of T1313A, a new mutation of the skeletal muscle sodium channel causing paramyotonia congenita in humans.
Bouhours M; Sternberg D; Davoine CS; Ferrer X; Willer JC; Fontaine B; Tabti N
J Physiol; 2004 Feb; 554(Pt 3):635-47. PubMed ID: 14617673
[TBL] [Abstract][Full Text] [Related]
6. Sodium channel mutations in paramyotonia congenita uncouple inactivation from activation.
Chahine M; George AL; Zhou M; Ji S; Sun W; Barchi RL; Horn R
Neuron; 1994 Feb; 12(2):281-94. PubMed ID: 8110459
[TBL] [Abstract][Full Text] [Related]
7. Slow inactivation differs among mutant Na channels associated with myotonia and periodic paralysis.
Hayward LJ; Brown RH; Cannon SC
Biophys J; 1997 Mar; 72(3):1204-19. PubMed ID: 9138567
[TBL] [Abstract][Full Text] [Related]
8. Gating of myotonic Na channel mutants defines the response to mexiletine and a potent derivative.
Desaphy JF; De Luca A; Tortorella P; De Vito D; George AL; Conte Camerino D
Neurology; 2001 Nov; 57(10):1849-57. PubMed ID: 11723275
[TBL] [Abstract][Full Text] [Related]
9. Sodium channel mutations in acetazolamide-responsive myotonia congenita, paramyotonia congenita, and hyperkalemic periodic paralysis.
Ptáĉek LJ; Tawil R; Griggs RC; Meola G; McManis P; Barohn RJ; Mendell JR; Harris C; Spitzer R; Santiago F
Neurology; 1994 Aug; 44(8):1500-3. PubMed ID: 8058156
[TBL] [Abstract][Full Text] [Related]
10. Activation and inactivation of the voltage-gated sodium channel: role of segment S5 revealed by a novel hyperkalaemic periodic paralysis mutation.
Bendahhou S; Cummins TR; Tawil R; Waxman SG; Ptácek LJ
J Neurosci; 1999 Jun; 19(12):4762-71. PubMed ID: 10366610
[TBL] [Abstract][Full Text] [Related]
11. Defective slow inactivation of sodium channels contributes to familial periodic paralysis.
Hayward LJ; Sandoval GM; Cannon SC
Neurology; 1999 Apr; 52(7):1447-53. PubMed ID: 10227633
[TBL] [Abstract][Full Text] [Related]
12. A1152D mutation of the Na+ channel causes paramyotonia congenita and emphasizes the role of DIII/S4-S5 linker in fast inactivation.
Bouhours M; Luce S; Sternberg D; Willer JC; Fontaine B; Tabti N
J Physiol; 2005 Jun; 565(Pt 2):415-27. PubMed ID: 15790667
[TBL] [Abstract][Full Text] [Related]
13. Human Na+ channel fast and slow inactivation in paramyotonia congenita mutants expressed in Xenopus laevis oocytes.
Richmond JE; Featherstone DE; Ruben PC
J Physiol; 1997 Mar; 499 ( Pt 3)(Pt 3):589-600. PubMed ID: 9130156
[TBL] [Abstract][Full Text] [Related]
14. N1366S mutation of human skeletal muscle sodium channel causes paramyotonia congenita.
Ke Q; Ye J; Tang S; Wang J; Luo B; Ji F; Zhang X; Yu Y; Cheng X; Li Y
J Physiol; 2017 Nov; 595(22):6837-6850. PubMed ID: 28940424
[TBL] [Abstract][Full Text] [Related]
15. Paramyotonia congenita and hyperkalemic periodic paralysis map to the same sodium-channel gene locus.
Ptacek LJ; Trimmer JS; Agnew WS; Roberts JW; Petajan JH; Leppert M
Am J Hum Genet; 1991 Oct; 49(4):851-4. PubMed ID: 1654742
[TBL] [Abstract][Full Text] [Related]
16. A novel sodium channel mutation causing a hyperkalemic paralytic and paramyotonic syndrome with variable clinical expressivity.
Wagner S; Lerche H; Mitrovic N; Heine R; George AL; Lehmann-Horn F
Neurology; 1997 Oct; 49(4):1018-25. PubMed ID: 9339683
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the muscle sodium channel gene (SCN4A) in 13 French families with hyperkalemic periodic paralysis and paramyotonia congenita: phenotype to genotype correlations and demonstration of the predominance of two mutations.
Plassart E; Reboul J; Rime CS; Recan D; Millasseau P; Eymard B; Pelletier J; Thomas C; Chapon F; Desnuelle C
Eur J Hum Genet; 1994; 2(2):110-24. PubMed ID: 8044656
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of cold sensitivity of paramyotonia congenita mutation R1448H and overlap syndrome mutation M1360V.
Mohammadi B; Mitrovic N; Lehmann-Horn F; Dengler R; Bufler J
J Physiol; 2003 Mar; 547(Pt 3):691-8. PubMed ID: 12562902
[TBL] [Abstract][Full Text] [Related]
19. Temperature-sensitive defects in paramyotonia congenita mutants R1448C and T1313M.
Dice MS; Abbruzzese JL; Wheeler JT; Groome JR; Fujimoto E; Ruben PC
Muscle Nerve; 2004 Sep; 30(3):277-88. PubMed ID: 15318338
[TBL] [Abstract][Full Text] [Related]
20. Ranolazine block of human Na v 1.4 sodium channels and paramyotonia congenita mutants.
El-Bizri N; Kahlig KM; Shyrock JC; George AL; Belardinelli L; Rajamani S
Channels (Austin); 2011; 5(2):161-72. PubMed ID: 21317558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
